Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03081871 · ClinicalTrials.gov registry record · NA
Mobile Cardiovascular Risk Service Trial
A NA study, sponsored by University of Iowa.
- Completed
- Registry status
- NA
- Development phase
- 80
- Enrollment target
NCT03081871: Completed NA study, sponsored by University of Iowa.
NCT03081871 is a NA study that has completed, run by University of Iowa. The registered enrollment target is 80 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03081871, a NA study, has completed, sponsored by University of Iowa.
- COMPLETED
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
Study Summary
Risk factors for cardiovascular disease are poorly controlled even for patients who frequently visit their physician, leading to large numbers of preventable cardiovascular events such as heart attacks and strokes. Research from integrated healthcare systems suggests that risk factors can be controlled better and treatment strategies for cardiovascular disease can be markedly improved by using a centralized cardiovascular risk service (CVRS) managed by pharmacists. The investigators are confident that a pharmacist-managed mHealth CVRS can become a strategy in un-integrated healthcare settings to markedly reduce cardiovascular events in the United States.
Primary Outcome
Mean number of days on which a patient interacts with the cardiovascular risk service (using either mobile app or web-site)
Interventions
- OTHER Pharmacist-led cardiovascular risk service (CVRS)
- OTHER Mobile access to study Personal Health Record
- OTHER Web access to study Personal Health Record
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2017-09-01 |
| Est. Completion | 2018-08-31 |
| Phase | NA |
What the finished NCT03081871 record still lists
NCT03081871 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 3 interventions - of which Pharmacist-led cardiovascular risk service (CVRS) is the first listed.
NCT03081871 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03081871 about?
NCT03081871 is a clinical study titled "Mobile Cardiovascular Risk Service Trial". Risk factors for cardiovascular disease are poorly controlled even for patients who frequently visit their physician, leading to large numbers of preventable cardiovascular events such as heart attacks and strokes. Research from integrated healthcare systems suggests that risk factors can be control...
What is the current status of trial NCT03081871?
This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2017-09-01. Estimated completion is 2018-08-31.
What interventions are being tested in trial NCT03081871?
The interventions under investigation include: Pharmacist-led cardiovascular risk service (CVRS) (OTHER), Mobile access to study Personal Health Record (OTHER), Web access to study Personal Health Record (OTHER).
Who is sponsoring clinical trial NCT03081871?
This trial is sponsored by University of Iowa, which has 228 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03081871's enrollment target sits among peer trials
80 994th of 2000 higher than 941 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI